Bulletin 290 launched - Branded generic medicines

This bulletin discusses the principles of branded generic prescribing, where it may be appropriate and where it isn't appropriate.

It does not provide recommended formulary choices or suggest that CCGs should recommend branded generic prescribing but does give options for local discussion.

A flow chart is available to support local decision making.

View >>